AU2002321743A1 - Sustained release pharmaceutical composition of a cephalosporin antibiotic - Google Patents
Sustained release pharmaceutical composition of a cephalosporin antibioticInfo
- Publication number
- AU2002321743A1 AU2002321743A1 AU2002321743A AU2002321743A AU2002321743A1 AU 2002321743 A1 AU2002321743 A1 AU 2002321743A1 AU 2002321743 A AU2002321743 A AU 2002321743A AU 2002321743 A AU2002321743 A AU 2002321743A AU 2002321743 A1 AU2002321743 A1 AU 2002321743A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical composition
- sustained release
- release pharmaceutical
- cephalosporin antibiotic
- cephalosporin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2002/003320 WO2004016250A1 (en) | 2002-08-19 | 2002-08-19 | Sustained release pharmaceutical composition of a cephalosporin antibiotic |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002321743A1 true AU2002321743A1 (en) | 2004-03-03 |
Family
ID=31726509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002321743A Abandoned AU2002321743A1 (en) | 2002-08-19 | 2002-08-19 | Sustained release pharmaceutical composition of a cephalosporin antibiotic |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002321743A1 (en) |
WO (1) | WO2004016250A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7722674B1 (en) | 2005-08-12 | 2010-05-25 | Innvotec Surgical Inc. | Linearly expanding spine cage for enhanced spinal fusion |
US7985256B2 (en) | 2005-09-26 | 2011-07-26 | Coalign Innovations, Inc. | Selectively expanding spine cage, hydraulically controllable in three dimensions for enhanced spinal fusion |
US9028550B2 (en) | 2005-09-26 | 2015-05-12 | Coalign Innovations, Inc. | Selectively expanding spine cage with enhanced bone graft infusion |
US8070813B2 (en) | 2005-09-26 | 2011-12-06 | Coalign Innovations, Inc. | Selectively expanding spine cage, hydraulically controllable in three dimensions for vertebral body replacement |
US20100145455A1 (en) | 2008-12-10 | 2010-06-10 | Innvotec Surgical, Inc. | Lockable spinal implant |
US8992620B2 (en) | 2008-12-10 | 2015-03-31 | Coalign Innovations, Inc. | Adjustable distraction cage with linked locking mechanisms |
US8696751B2 (en) | 2008-12-10 | 2014-04-15 | Coalign Innovations, Inc. | Adjustable distraction cage with linked locking mechanisms |
US8932355B2 (en) | 2008-02-22 | 2015-01-13 | Coalign Innovations, Inc. | Spinal implant with expandable fixation |
CN103211795B (en) * | 2012-01-18 | 2017-07-11 | 北京天衡药物研究院有限公司 | Cefaclor film-controlled slow-release micro pill capsule |
CN103432095A (en) * | 2013-09-11 | 2013-12-11 | 中国药科大学 | Intra-gastric floating sustained-release preparation of cefalexin and preparation method thereof |
JP6943598B2 (en) | 2016-04-07 | 2021-10-06 | ハウメディカ・オステオニクス・コーポレイション | Expandable interbody implant |
US10940018B2 (en) | 2016-05-20 | 2021-03-09 | Howmedica Osteonics Corp. | Expandable interbody implant with lordosis correction |
EP3292841B8 (en) | 2016-09-12 | 2023-05-31 | Howmedica Osteonics Corp. | Interbody implant with independent control of expansion at multiple locations |
AU2017251734B2 (en) | 2016-10-26 | 2022-10-20 | Howmedica Osteonics Corp. | Expandable interbody implant with lateral articulation |
EP3456294B1 (en) | 2017-09-15 | 2024-06-05 | Stryker European Operations Holdings LLC | Intervertebral body fusion device expanded with hardening material |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6080427A (en) * | 1997-04-17 | 2000-06-27 | Bristol-Myers Squibb Company | Cefadroxil monohydrate tablet formulation |
WO2002041876A1 (en) * | 2000-11-22 | 2002-05-30 | Lupin Limited | Pharmaceutical composition for controlled release of an active ingredient |
ES2248521T3 (en) * | 2001-02-27 | 2006-03-16 | Ranbaxy Laboratories, Ltd. | ORAL PHARMACEUTICAL COMPOSITION OF CEFPODOXIMA PROXETILO. |
-
2002
- 2002-08-19 WO PCT/IB2002/003320 patent/WO2004016250A1/en not_active Application Discontinuation
- 2002-08-19 AU AU2002321743A patent/AU2002321743A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004016250A1 (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1581236A3 (en) | Sustained release of antiinfectives | |
AU2003291103A1 (en) | Pharmaceutical composition | |
AU2003296897A1 (en) | Pharmaceutical formulations of camptothecine derivatives | |
AU2002248377A1 (en) | A controlled release pharmaceutical composition | |
AU2002321743A1 (en) | Sustained release pharmaceutical composition of a cephalosporin antibiotic | |
AU2003290734A1 (en) | Novel compounds as pharmaceutical agents | |
AU2003260803A1 (en) | Sustained release pharmaceutical composition | |
AU2002337803A1 (en) | Sustained release pharmaceutical compositions | |
AU2003250372A1 (en) | Pharmaceutical composition | |
AUPR602501A0 (en) | Sustained release pharmaceutical composition | |
AU2003226189A1 (en) | Oral administration of epothilones | |
AU2003245504A1 (en) | Pharmaceutical compositions for drugs having ph-dependentsolubility | |
AU2002364468A1 (en) | Solid orally-dispersible pharmaceutical formulation | |
AU2003241671A1 (en) | Controlled-release drug composition | |
AU2002950657A0 (en) | Derivatives of monosaccharides for drug discovery | |
AU2003290394A1 (en) | Extended release formulation of beta-lactam antibiotics | |
AU2003255874A1 (en) | Sustained release pharmaceutical composition of a cephalosporin antibiotic | |
AU2003281268A1 (en) | Cephalosporin preparation for oral use | |
AUPS213802A0 (en) | Disaccharides for drug discovery | |
AU2003291642A1 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
AU2003284460A1 (en) | Medicinal composition | |
AU2003208621A1 (en) | A pharmaceutical composition | |
AU2003262141A1 (en) | Preperation of desloratatine | |
AU2003209533A1 (en) | Process of manufacturing pharmaceutical composition useful for management of tuberculosis | |
AU2003274410A1 (en) | Pharmaceutical compositions of ganciclovir |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |